Samantha Semenkow
Stock Analyst at Citigroup
(0)
# 4902
Out of 5,340 analysts
51
Total ratings
21.74%
Success rate
-26.18%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CABA Cabaletta Bio | Maintains: Buy | 17 13 | 1.98 | 556.57% | 3 | May 16, 2025 | |
ALLO Allogene Therapeutic... | Maintains: Buy | 8 4 | 1.11 | 260.36% | 3 | May 15, 2025 | |
ARGX argenx | Maintains: Strong Buy | 796 803 | 568.78 | 41.18% | 6 | May 9, 2025 | |
GPCR Structure Therapeuti... | Initiates Coverage On: Buy | 60 | 25.15 | 138.57% | 1 | May 2, 2025 | |
BIOA Bioage Labs | Maintains: Neutral | 7 5 | 3.92 | 27.55% | 3 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 3 | 2.25 | 33.33% | 2 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | 3.41 | 251.91% | 1 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 27 31 | 24.41 | 27% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 8 15 | 1.75 | 757.14% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Buy | 4 | 0.33 | 1112.12% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 10 14 | 1.89 | 640.74% | 6 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 10 | 1.3 | 669.23% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 16 15 | 1.46 | 927.4% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 9 12 | 5 | 140% | 2 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 72 | 38.75 | 85.81% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 46 | n/a | n/a | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 33 50 | 14.56 | 243.41% | 3 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 60 56 | 17.55 | 219.09% | 3 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 2 1 | n/a | n/a | 3 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 6 | n/a | n/a | 1 | May 3, 2023 |